Thermal nucleation effect in the crystallization of metallic glasses von Tsarev, G. L., Voloshin, Yu. N.

Volltext

The Structure and Properties of an Amorphous Powder Material After Explosive Loading von Roman, O V, Bogdanov, A P, Voloshin, Y U N, Gorobtsov, V G, Pikus, I M

Volltext

Global Λ hyperon polarization in nuclear collisions von Agakishiev, G., Ahammed, Z., Aoyama, R., Arkhipkin, D., Behera, A., Bielcik, J., Bland, L. C., Brandin, A. V., Butterworth, J., Campbell, J. M., Chakaberia, I., Chaloupka, P., Crawford, H. J., Dedovich, T. G., Didenko, L., Drachenberg, J. L., Dunkelberger, L. E., Fatemi, R., Federic, P., Federicova, P., Fisyak, Y., Garand, D., He, L., Heppelmann, S., Huang, X., Humanic, T. J., Huo, P., Igo, G., Jowzaee, S., Kalinkin, D., Kauder, K., Kechechyan, A., Khan, Z., Kikoła, D. P., Kocmanek, M., Kraishan, A. F., Kvapil, J., Lauret, J., Lednicky, R., Li, X., Li, W., Li, Y., Liu, Y., Liu, F., Lomnitz, M., Ma, G. L., Matis, H. S., Meehan, K., Mei, J. C., Miller, Z. W., Nasim, Md, Nelson, J. M., Odyniec, G., Pak, R., Perkins, C., Pile, P., Poskanzer, A. M., Qiu, H., Quintero, A., Ramachandran, S., Ray, R. L., Reed, R., Rehbein, M. J., Ritter, H. G., Roberts, J. B., Romero, J. L., Roth, J. D., Sahoo, N. R., Schmah, A. M., Schmidke, W. B., Seger, J., Shah, N., Singha, S., Skoby, M. J., Smirnov, N., Song, L., Stanislaus, T. D. S., Strikhanov, M., Sugiura, T., Sumbera, M., Sun, Y., Sun, X., Surrow, B., Tang, Z., Tawfik, A., Trentalange, S., Tribble, R. E., Underwood, D. G., van Nieuwenhuizen, G., Vasiliev, A. N., Vokal, S., Voloshin, S. A., Webb, G., Xu, J., Yang, Q., Yang, C., Yoo, I. -K., Zhang, J. B., Zhang, S., Zhu, Z.

Volltext

Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study von Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Osterborg, Anders, Robak, Tadeusz, Simkovic, Martin, Stevens, Don, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianya, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Caces, Donne Bennett, Niemann, Carsten U, Kater, Arnon P

Volltext

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymp... von Chanan-Khan, Asher, Prof, Cramer, Paula, MD, Demirkan, Fatih, MD, Fraser, Graeme, MD, Silva, Rodrigo Santucci, MD, Grosicki, Sebastian, Prof, Pristupa, Aleksander, MD, Janssens, Ann, MD, Mayer, Jiri, Prof, Bartlett, Nancy L, Prof, Dilhuydy, Marie-Sarah, MD, Pylypenko, Halyna, MD, Loscertales, Javier, MD, Avigdor, Abraham, MD, Rule, Simon, Prof, Villa, Diego, MD, Samoilova, Olga, MD, Panagiotidis, Panagiots, Prof, Goy, Andre, MD, Mato, Anthony, MD, Pavlovsky, Miguel A, MD, Karlsson, Claes, MD, Mahler, Michelle, MD, Salman, Mariya, PhD, Sun, Steven, PhD, Phelps, Charles, MS, Balasubramanian, Sriram, PhD, Howes, Angela, PhD, Hallek, Michael, MD

Volltext

Tumor Treating Fields (150kHz) combined with FOLFOX inhibits gastric cancer in vitro von Zeevi, E., Gotlib, K., Shnaiderman, R., Munster, M., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Giladi, M., Kirson, E., Weinberg, U., Kinzel, A., Palti, Y.

Volltext

Efficacy of 150kHz tumor treating fields (TTFields) and cisplatin or pemetrexed for the treatment of mesothelioma cells in vitro von Weinberg, U., Munster, M., Gotlib, K., Schneiderman, R.S., Porat, Y., Voloshin Sela, T., Davidi, S., Shteingauz, A., Kaynan, N., Zeevi, E., Giladi, M., Kirson, E., Kinzel, A., Palti, Y.

Volltext

P-121 Effects of tumor treating fields (TTFields) on gastric cancer cells and their potential concomitant application with FOLFOX von Flint-Brodsly, N., Zeevi, E., Dor-On, E., Schneiderman, R., Munster, M., Porat, Y., Voloshin, T., Davidi, S., León, J., Haber, A., Giladi, M., Weinberg, U., Palti, Y.

Volltext

P-99 Tumor treating fields (TTFields) are effective for treatment of gastric cancer cells, boosting the activity of FOLFOX von Flint-Brodsly, N., Zeevi, E., Fishman, H., Ene, H., Martinez-Conde, A., Frechtel-Gerzi, R., Wainer-Katsir, K., Dor-On, E., Porat, Y., Voloshin, T., Haber, A., Giladi, M., Weinberg, U., Palti, Y.

Volltext

Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models von Weinberg, U., Kaynan, N., Voloshin Sela, T., Davidi, S., Porat, Y., Shteingauz, A., Munster, M., Schneiderman, R.S., Tempel Brami, C., Zeevi, E., Gotlib, K., Cahal, S., Giladi, M., Kirson, E., Kinzel, A., Palti, Y.

Volltext

P-255 Effects of tumor treating fields (150 kHz) in combination with FOLFOX on gastric cancer cells in vitro von Zeevi, E., Gotlib, K., Schneiderman, R., Munster, M., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Giladi, M., Weinberg, U., Palti, Y.

Volltext

1852P - Effects of tumor treating fields (TTFields; 150 kHz) and cisplatin or pemetrexed combination therapy on mesothelioma cells in vitro and in vivo von Munster, M., Gotlib, K., Schneiderman, R.S., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Zeevi, E., Giladi, M., Kirson, E.D., Weinberg, U., Kinzel, A., Palti, Y.

Volltext

Effects of tumor treating fields (TTFields; 150 kHz) and cisplatin or pemetrexed combination therapy on mesothelioma cells in vitro and in vivo von Munster, M., Gotlib, K., Schneiderman, R.S., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Zeevi, E., Giladi, M., Kirson, E.D., Weinberg, U., Kinzel, A., Palti, Y.

Volltext

Animal Studies Evaluating the Safety of Tumor Treating Fields (TTFields) Alone and in Combination with Chemotherapy Agents Demonstrate No Additional Toxicities von Giladi, M., Davidi, S., Munster, M., Schneiderman, R.S., Kaynan, N., Voloshin, T., Porat, Y., Cahal, S., Kirson, E., Weinberg, U., Palti, Y.

Volltext

Efficacy of Tumor Treating Fields (TTFields) in Combination with Cisplatin or Pemetrexed for the Treatment of Mesothelioma in Vitro and in Vivo von Munster, M., Gotlib, K., Schneiderman, R.S., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Zeevi, E., Giladi, M., Kirson, E., Weinberg, U., Kinzel, A., Palti, Y.

Volltext

Immunogenic Cell Death Induced by Tumor Treating Fields (TTFields) Enhances Efficacy When Combined with Anti-PD-1 Therapy in Lung and Colon Cancer Animal Models von Voloshin, T., Kaynan, N., Davidi, S., Porat, Y., Schneiderman, R.S., Zeevi, E., Gotlib, K., Blatt, R., Cahal, S., Giladi, M., Kirson, E., Weinberg, U., Palti, Y.

Volltext

The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and FOLFOX Inhibit Gastric Cancer in Vitro von Zeevi, E., Gotlib, K., Schneiderman, R.S., Munster, M., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Giladi, M., Kirson, E., Weinberg, U., Kinzel, A., Palti, Y.

Volltext

P-228Tumor Treating Fields (150 kHz) combined with FOLFOX inhibits gastric cancer in vitro von Zeevi, E, Gotlib, K, Shnaiderman, R, Munster, M, Porat, Y, Voloshin, T, Davidi, S, Shteingauz, A, Kaynan, N, Giladi, M, Kirson, E, Weinberg, U, Kinzel, A, Palti, Y

Volltext

The Combined Treatment of 150 kHz Tumor Treating Fields (TTFields) and Cisplatin or Pemetrexed Inhibit Mesothelioma Cells In Vitro von Munster, M., Schneiderman, R.S., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Zeevi, E., Gotlib, K., Giladi, M., Kirson, E., Weinberg, U., Kinzel, A., Palti, Y.

Volltext

P1.06-17 Tumor Treating Fields (150 kHz) Combined with Cisplatin or Pemetrexed Inhibits Mesothelioma Cells in Vitro and in Vivo von Munster, M., Gotlib, K., Schneiderman, R., Porat, Y., Voloshin, T., Davidi, S., Shteingauz, A., Kaynan, N., Zeevi, E., Giladi, M., Kirson, E., Weinberg, U., Kinzel, A., Palti, Y.

Volltext